menu search

MLAB / Bull of the Day: Mesa Laboratories (MLAB)

Bull of the Day: Mesa Laboratories (MLAB)
Key M&A boosts sales & EPS, opens path to new business with Clinical Genomics Division Read More
Posted: Oct 8 2021, 06:26
Author Name: Zacks Investment Research
Views: 111847

MLAB News  

Bear of the Day: Mesa Labs (MLAB)

By Zacks Investment Research
September 22, 2023

Bear of the Day: Mesa Labs (MLAB)

Mesa Labs ( MLAB ) is a small-cap medical provider of quality control monitoring and validation instruments serving niche markets in healthcare, indus more_horizontal

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023

By GlobeNewsWire
September 13, 2023

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023

LAKEWOOD, Colo., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the se more_horizontal

Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023

By GlobeNewsWire
June 21, 2023

Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023

LAKEWOOD, Colo., June 21, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the fir more_horizontal

Mesa Labs (MLAB) Q4 Earnings and Revenues Miss Estimates

By Zacks Investment Research
May 25, 2023

Mesa Labs (MLAB) Q4 Earnings and Revenues Miss Estimates

Mesa Labs (MLAB) came out with quarterly earnings of $1.94 per share, missing the Zacks Consensus Estimate of $1.98 per share. This compares to earnin more_horizontal

Mesa Laboratories: Divisional Growth, Valuations Supportive Of Hold

By Seeking Alpha
February 27, 2023

Mesa Laboratories: Divisional Growth, Valuations Supportive Of Hold

In Q3, Mesa Laboratories reported mixed results throughout the P&L with soft bottom-line fundamentals. FCF growth still lumpy with contraction in divi more_horizontal

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

By Zacks Investment Research
February 14, 2023

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now. more_horizontal

Is Mesa Labs (MLAB) a Solid Growth Stock? 3 Reasons to Think

By Zacks Investment Research
February 13, 2023

Is Mesa Labs (MLAB) a Solid Growth Stock? 3 Reasons to Think "Yes"

Mesa Labs (MLAB) is well positioned to outperform the market, as it exhibits above-average growth in financials. more_horizontal

What's in the Cards for Mesa Laboratories' (MLAB) Q3 Earnings?

By Zacks Investment Research
February 1, 2023

What's in the Cards for Mesa Laboratories' (MLAB) Q3 Earnings?

Continued strength in Mesa Laboratories' (MLAB) Clinical Genomics segment is expected to have driven up Q3 sales. more_horizontal


Search within

Pages Search Results: